BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8552269)

  • 1. [Nationwide drug surveillance project on slow-release nicardipine in the short-term therapy of light/moderate arterial hypertension].
    Benvenuti C; Guerini Rocco C; Trezzi P
    Minerva Cardioangiol; 1995 Sep; 43(9):399-408. PubMed ID: 8552269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of slow-release nicardipine on blood pressure, renal function and the renin-angiotensin-aldosterone system in patients with mild-to-moderate essential arterial hypertension].
    Melina D; Guerrera G; Santoliquido A; Colivicchi F; Melina G; Musumeci V; Guerrera C
    Clin Ter; 1991 Nov 15-30; 139(3-4):101-6. PubMed ID: 1837249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on casual and 24-h ambulatory blood pressure of slow-release nicardipine and chlorthalidone in arterial essential hypertension: double-blind, crossover study.
    Celentano A; Galderisi M; Tammaro P; Mureddu GF; Garofalo M; de Divitiis O
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):190-6. PubMed ID: 2365538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of nicardipine in 29,104 patients with hypertension.
    Dubois C; Blanchard D
    Clin Ther; 1989; 11(4):452-60. PubMed ID: 2673515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicardipine in severe hypertension: oral therapy following intravenous treatment.
    Wallin JD; Bienvenu GS; Cook E; Laddu A; Turlapaty P; Clifton GG
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):14-9. PubMed ID: 2303309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Slow-release nicardipine in the treatment of arterial hypertension: comparative study vs. an ACE inhibitor].
    De Cesaris R; Ranieri G; Bonfantino V; Adriani A; Filitti V; Ferrieri A
    Minerva Cardioangiol; 1993 Oct; 41(10):457-63. PubMed ID: 8302442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive effect and tolerability of slow-release nicardipine].
    Fogari R; Poletti L; Tettamanti F; Malamani G; Borgnino C
    Cardiologia; 1989 Feb; 34(2):161-5. PubMed ID: 2660993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and tolerability of nicardipine retard and captopril in hypertension in the aged. Results of a multicenter study].
    Mancia G; Buoninconti R; Errico M; Freda M; Giordano MP; Granata Q; Lucentini ML; Marsili P; Pasotti C; Piccolo E
    Minerva Med; 1992 Nov; 83(11):731-8. PubMed ID: 1461544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of arterial hypertension in the aged with a calcium antagonist: nicardipine].
    Forette F; Bellet M; Henry JF; Hervy MP; Poyard-Salmeron C; Bouchacourt P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1242-6. PubMed ID: 6441544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicardipine retard in the therapy of elderly diabetic hypertensives: final report of observational study.
    Antonicelli R; Pagelli P; Paciaroni E
    J Hypertens Suppl; 1992 Apr; 10(2):S69-72. PubMed ID: 1593306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W; Wilson T
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol.
    Elatrous S; Nouira S; Ouanes Besbes L; Marghli S; Boussarssar M; Sakkouhi M; Abroug F
    Intensive Care Med; 2002 Sep; 28(9):1281-6. PubMed ID: 12209278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.